Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Chataway

Showing results (101-110 of 182) with videos related to

Pageof 19
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|January 15, 2022
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled TrialThomas E Williams, Katherine P Holdsworth, Jennifer M Nicholas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2015
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseasesNidhi Garg, Stephen W Reddel, David H Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 6, 2021
Vaccination and multiple sclerosis in the era of the COVID-19 pandemicTobias Monschein, Hans-Peter Hartung, Tobias Zrzavy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing diversity of clinical trial populations in multiple sclerosisRuth Ann Marrie, Jeremy Chataway, Barbara E Bierer, et al.
European Journal of Neurology|February 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple SclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing involvement of people with multiple sclerosis in clinical trial designEmma Gray, Anneesa Amjad, Jenny Robertson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2023
Leukoencephalopathy caused by a 17p13.3 microdeletionCharles Wade, Thomas Williams, Robyn Labrum, et al.
Patient Education and Counseling|May 28, 2020
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosisAna Manzano, Ieva Eskytė, Helen L Ford, et al.
Stem Cells Translational Medicine|August 10, 2014
Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic StrokeSoma Banerjee, Paul Bentley, Mohammad Hamady, et al.
The Patient|January 10, 2018
A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple SclerosisEdward J D Webb, David Meads, Ieva Eskyte, et al.
Pageof 19

Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Neurology(R) Neuroimmunology & Neuroinflammation|January 15, 2022
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled TrialThomas E Williams, Katherine P Holdsworth, Jennifer M Nicholas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 11, 2015
The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseasesNidhi Garg, Stephen W Reddel, David H Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 6, 2021
Vaccination and multiple sclerosis in the era of the COVID-19 pandemicTobias Monschein, Hans-Peter Hartung, Tobias Zrzavy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing diversity of clinical trial populations in multiple sclerosisRuth Ann Marrie, Jeremy Chataway, Barbara E Bierer, et al.
European Journal of Neurology|February 10, 2026
Vascular Comorbidities and an Increased Comorbidity Score Are Associated With Disability and Disability Progression in Secondary Progressive Multiple SclerosisNevin A John, Yingtong Li, Floriana De Angelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Enhancing involvement of people with multiple sclerosis in clinical trial designEmma Gray, Anneesa Amjad, Jenny Robertson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2023
Leukoencephalopathy caused by a 17p13.3 microdeletionCharles Wade, Thomas Williams, Robyn Labrum, et al.
Patient Education and Counseling|May 28, 2020
Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosisAna Manzano, Ieva Eskytė, Helen L Ford, et al.
Stem Cells Translational Medicine|August 10, 2014
Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic StrokeSoma Banerjee, Paul Bentley, Mohammad Hamady, et al.
The Patient|January 10, 2018
A Systematic Review of Discrete-Choice Experiments and Conjoint Analysis Studies in People with Multiple SclerosisEdward J D Webb, David Meads, Ieva Eskyte, et al.
Pageof 19